These findings support the idea that some patients may have partial biologic resistance to incretin-based therapies, said Robert Glatter, MD, attending physician in the Department of Emergency Medicine at Lenox Hill Hospital in New York City, and Assistant Professor of Emergency Medicine at Zucker School of Medicine at Hofstra/ Northwell
99 Similarly, a study done in Singapore found participants with both a BMI 23 kg/m 2 and waist-to-height ratio 0.5 had the highest cardiovascular risk
GLP-1 medications such as Semaglutide (Ozempic), Wegovy, Tirzepatide (Mounjaro), and Zepbound have become increasingly popular for weight loss and metabolic health
In practice, an indication is not just a description of use
68)Ga-NODAGA-Exendin-4 PET/CT improves the detection of focal congenital hyperinsulinism